Rating History for Inhibikase Therapeutics Inc (IKT) by Oppenheimer

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/10/2026 Mazahir Alimohamed New Coverage Outperform
(N/A)
5.00
(N/A)
1.67
(1.87)
11.98% Details